Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Shrinking team NBB
FTE fell two years in a row, from 1.8 to 0.
-
Board fully replaced NBB
No director from three years ago is still active according to annual account 2024.
-
Busy address KBO
98 other companies have their registered office at the same address; threshold 10.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2024
SEBBIN BENELUX from Elsene, company number BE0841719676, closed financial year 2024 with a result of € -15,822 after tax. For that financial year SEBBIN BENELUX recorded a gross margin of € 8,008 and equity of € 214,010. Compared with financial year 2023, the result moved from € 1,448 to € -15,822. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on March 31, 2025.
€ 214,010
▼ 7% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -15,822
▼ still € 1,448 profit in 2023
Profit after tax over the fiscal year.
€ 5,817
▼ 11% vs 2023
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -160,990.
People and assets in 2024
0
▼ 0.5 vs 2023
Average over the fiscal year, from the social balance sheet.
€ 658
▼ 99% vs 2023
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2024
None
No bank loans on the last day of the fiscal year.
€ 4,829
▼ 77% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 6,026
▼ 89% vs 2023
Taxes, VAT and social contributions still to pay.
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € 391,887 | € 275,252 | € 83,145 | € 8,008 | ▼ 90% |
| Profit after taxes | € 15,596 | € 22,321 | € 1,448 | € -15,822 | ▼ € 17,270 |
| Equity | € 206,063 | € 228,384 | € 229,833 | € 214,010 | ▼ 7% |
| Total debts | € 106,781 | € 52,186 | € 76,272 | € 10,855 | ▼ 86% |
| Cash | € 19,228 | € 26,791 | € 6,535 | € 5,817 | ▼ 11% |
| Retained profit | € -168,937 | € -146,616 | € -145,167 | € -160,990 | ▼ € 15,822 |
| Balance sheet total | € 312,844 | € 280,570 | € 306,105 | € 224,866 | ▼ 27% |
| Employees (FTE) | - | 1.8 | 0.5 | 0 | ▼ 0.5 |
By gross margin, SEBBIN BENELUX ranks 15th of 21 companies with main activity “Groothandel in farmaceutische en medische artikelen” in Elsene that publish figures (fiscal year 2024).
Key figures of SEBBIN BENELUX, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
Ask about SEBBIN BENELUX the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to SEBBIN BENELUX?
What happened at SEBBIN BENELUX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: loss of € 15,822 (▼ € 17,270 vs 2023). Source: NBB ↗
- Patrick Lichtle became a director. NBB
- Jean-Paul Gerardin became a director. NBB
- Benoit Durand stepped down as director. NBB
- Benoit Durand became a director. NBB
- Capital increase of € 345,000, published in the Gazette. Source: Staatsblad ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Elsene. KBO
In short
From € 15,596 profit in 2021 to € 15,822 loss in 2024.
Paid € 35,849 in corporate taxes since 2021.
Best year ever: 2022, with € 22,321 profit.
On average € 152,900 of value added per employee in 2022.
Management
Behind SEBBIN BENELUX are Patrick Lichtle and Jean-Paul Gerardin.
Directors
According to the 2024 annual accounts
Patrick Lichtle
Director
since 2024
Jean-Paul Gerardin
Director
since 2024
Benoit Durand
Director
since 2018 · until 2024
Establishments
Establishment units
Physical locations of this company
Arnaud Fraiteurlaan 15-23 box 4A
1050 Elsene
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 98 companies are registered at this address.
All companies at this address →SMT Africa
€ 343.2 million revenue · 2025
NEW SOLUTIONS
€ -46,301 gross margin · 2025
Atrio architectuur
€ -1,579 gross margin · 2025
D.L.C.
€ 902,089 gross margin · 2026
IMMOBILIERE A.S.H.
€ 19,105 gross margin · 2024
+93 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Elsene
Same main activity (Groothandel in farmaceutische en medische artikelen), 32 active companies in Elsene, largest first.
€ 164.7 million revenue · 2025
€ 96.9 million revenue · 2025
Boehringer Ingelheim Animal Health Belgium SA
€ 50.6 million revenue · 2025
€ 23.5 million revenue · 2025
€ 21.4 million revenue · 2026
€ 16.2 million revenue · 2025
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Capital increase
Source: Deed ↗- GROUPE SEBBIN(aandeelhouder)
Incorporation
Source: Deed ↗- P.V.P.SAS(oprichter) 98.7%
- Olivier Pérusseau(oprichter) 1%
- Diederik van Goor(oprichter) 0.3%
Details
- Company number
- 0841.719.676
- VAT number
- BE 0841.719.676
- Registered office
- Arnaud Fraiteurlaan 15-23 bus 4A, 1050 Elsene
- Names & denominations
- SEBBIN BENELUX
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 12 December 2011
- Peppol
- Not registered
- Activities · NACE
Groothandel in farmaceutische en medische artikelen